Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000602
Filing Date
2025-01-03
Accepted
2025-01-03 17:42:47
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01032025_100144.html 4  
1 form4-01032025_100144.xml 4 6473
  Complete submission text file 0001415889-25-000602.txt   7971
Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Multani Pratik S (Reporting) CIK: 0001586894 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 25508167

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)